Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Doctors might suggest this treatment for people who need to lose weight for health reasons, such as reducing the risk of heart disease or improving mobility
Optimal Health and Wellness sees patients as whole individuals with unique physical, emotional, and spiritual needs, emphasizing a comprehensive approach to health
"Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health ." Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated
Measurable weight loss typically appears in the second to fourth week as reduced caloric intake creates an energy deficit
Medication costs included if prescribed
